![]() |
|
![]() |
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
Sponsored by: |
M.D. Anderson Cancer Center |
Information provided by: | M.D. Anderson Cancer Center |
ClinicalTrials.gov Identifier: | NCT00429455 |
Primary Objective:
1. To understand the importance of receiving information on fertility- and menopause-related treatment effects for female patients undergoing hematopoietic stem cell transplantation.
Condition | Intervention |
Stem Cell Transplantation |
Behavioral: Questionnaire |
MedlinePlus related topics: | Menopause |
Study Type: | Observational |
Study Design: | Case-Only, Prospective |
Official Title: | Survey of the Need for Information on Fertility and Menopause-Related Treatment Effects Among Young Women Who Underwent Hematopoietic Stem Cell Transplantation |
Estimated Enrollment: | 640 |
Study Start Date: | March 2007 |
Estimated Primary Completion Date: | March 2009 (Final data collection date for primary outcome measure) |
Groups/Cohorts | Assigned Interventions |
1
Female patients who had a hematopoietic stem cell transplantation between January 1987 and September 2004 at M. D. Anderson Cancer Center.
|
Behavioral: Questionnaire
3-Part Questionnaire
|
We are currently conducting a survey on how important it is to women who are having a stem cell transplant to have information about the effects of the treatment on their fertility (their ability to have children) and on the risk of early menopause. We know that some women who had transplants think that the information that they received may have been lacking or was not appropriate for their needs. Therefore, we would like to ask women who have had stem cell transplants at M. D. Anderson Cancer Center to tell us what kind of information they got and would like to have gotten before or during their treatment.
Ages Eligible for Study: | 16 Years to 50 Years |
Genders Eligible for Study: | Female |
Accepts Healthy Volunteers: | No |
Sampling Method: | Probability Sample |
Female patients who had a hematopoietic stem cell transplantation between January 1987 and September 2004 at M. D. Anderson Cancer Center.
Inclusion Criteria:
Exclusion Criteria:
Contact: Naoto Ueno, MD, PhD | 713-792-8754 |
United States, Texas | |||||
U.T. M.D. Anderson Cancer Center | Recruiting | ||||
Houston, Texas, United States, 77030 | |||||
Principal Investigator: Naoto Ueno, MD, PhD |
M.D. Anderson Cancer Center |
Principal Investigator: | Naoto Ueno, MD, PhD | U.T. M.D. Anderson Cancer Center |
Responsible Party: | U.T.M.D. Anderson Cancer Center ( Naoto Ueno, MD, PhD/Associate Professor ) |
Study ID Numbers: | 2005-0997 |
First Received: | January 29, 2007 |
Last Updated: | June 13, 2008 |
ClinicalTrials.gov Identifier: | NCT00429455 |
Health Authority: | United States: Institutional Review Board |
|
|
![]() |